Madrigal Pharmaceuticals (MDGL) Short term Debt (2010 - 2016)

Madrigal Pharmaceuticals (MDGL) has 7 years of Short term Debt data on file, last reported at $10000.0 in Q2 2016.

• On a quarterly basis, Short term Debt fell 99.89% year-over-year to $10000.0 in Q2 2016; TTM through Jun 2016 was $10000.0, a 99.89% decrease from a year earlier, with the FY2015 full-year figure at $4.6 million, down 50.0% from the prior year.
• Short term Debt for Q2 2016 stood at $10000.0, down from $2.3 million in the prior quarter.
• Over the last five years, Short term Debt for MDGL reached as high as $9.5 million in Q4 2013 and fell as low as $10000.0 in Q2 2016.
• Historically, Short term Debt has averaged $6.9 million across 5 years, with a median of $7.9 million in 2012.
• Across the five-year window, Short term Debt surged 200.58% in 2014 and tumbled 99.89% in 2016, its largest moves.
• Year by year, Short term Debt stood at $7.9 million in 2012, then increased by 19.27% to $9.5 million in 2013, then decreased by 2.51% to $9.2 million in 2014, then slumped by 50.0% to $4.6 million in 2015, then slumped by 99.78% to $10000.0 in 2016.
• Per Business Quant data, the three most recent Short term Debt figures were $10000.0 in Q2 2016, $2.3 million in Q1 2016, and $4.6 million in Q4 2015.